Overexpression of receptor for advanced glycation end products (RAGE) in ovarian cancer

Siegel R. , Naishadham D. , and Jemal A. , Cancer statistics, 2012. CA Cancer J Clin 62 (2012) 10-29.

Heintz A.P. , Odicino F. , Maisonneuve P. , Quinn M.A. , Benedet J.L. , Creasman W.T. , Ngan H.Y. , Pecorelli S. , and Beller U. , Carcinoma of the ovary. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95(Suppl 1) (2006) S161-92.

Chien J. , Fan J.B. , Bell D.A. , April C. , Klotzle B. , Ota T. , Lingle W.L. , Gonzalez Bosquet J. , Shridhar V. , and Hartmann L.C. , Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer. Gynecol Oncol 114 (2009) 3-11.

Mabuchi S. , Sugiyama T. , and Kimura T. , Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives. J Gynecol Oncol 27 (2016) e31.

Tesarova P. , Cabinakova M. , Mikulova V. , Zima T. , and Kalousova M. , RAGE and its ligands in cancer-culprits, biomarkers, or therapeutic targets? Neoplasma 62 (2015) 353-64.

Moridi H. , Karimi J. , Sheikh N. , Goodarzi M.T. , Saidijam M. , Yadegarazari R. , Khazaei M. , Khodadadi I. , Tavilani H. , Piri H. , Asadi S. , Zarei S. , and Rezaei A. , Resveratrol-Dependent Down-regulation of Receptor for Advanced Glycation End-products and Oxidative Stress in Kidney of Rats With Diabetes. Int J Endocrinol Metab 13 (2015) e23542.

Nasser M.W. , Ahirwar D.K. , and Ganju R.K. , RAGE: A novel target for breast cancer growth and metastasis. Oncoscience 3 (2016) 52-3.

Livak K.J. , and Schmittgen T.D. , Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) Method. Methods 25 (2001) 402-8.

Zhu X. , Jin L. , Zou S. , Shen Q. , Jiang W. , Lin W. , and Zhu X. , Immunohistochemical expression of RAGE and its ligand (S100A9) in cervical lesions. Cell Biochem Biophys 66 (2013) 843-50.

Edge S.B. , and Compton C.C. , The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17 (2010) 1471-4.

Suh D.H. , Kim K. , and Kim J.W. , Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol 23 (2012) 53-64.

Kim Y. , Kim C. , Son S.M. , Song H. , Hong H.S. , Han S.H. , and Mook-Jung I. , The novel RAGE interactor PRAK is associated with autophagy signaling in Alzheimer's disease pathogenesis. Mol Neurodegener 11 (2016) 4.

Chen X. , Zhang L. , Zhang I.Y. , Liang J. , Wang H. , Ouyang M. , Wu S. , da Fonseca A.C. , Weng L. , Yamamoto Y. , Yamamoto H. , Natarajan R. , and Badie B. , RAGE expression in tumor-associated macrophages promotes angiogenesis in glioma. Cancer Res 74 (2014) 7285-97.

Poljicanin A. , Filipovic N. , Vukusic Pusic T. , Soljic V. , Caric A. , Saraga-Babic M. , and Vukojevic K. , Expression pattern of RAGE and IGF-1 in the human fetal ovary and ovarian serous carcinoma. Acta Histochem 117 (2015) 468-76.

Kuniyasu H. , Oue N. , Wakikawa A. , Shigeishi H. , Matsutani N. , Kuraoka K. , Ito R. , Yokozaki H. , and Yasui W. , Expression of receptors for advanced glycation end-products (RAGE) is closely associated with the invasive and metastatic activity of gastric cancer. J Pathol 196 (2002) 163-70.

Wang D. , Li T. , Ye G. , Shen Z. , Hu Y. , Mou T. , Yu J. , Li S. , Liu H. , and Li G. , Overexpression of the Receptor for Advanced Glycation Endproducts (RAGE) is associated with poor prognosis in gastric cancer. PLoS One 10 (2015) e0122697.

Hermani A. , De Servi B. , Medunjanin S. , Tessier P.A. , and Mayer D. , S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312 (2006) 184-97.

Kuniyasu H. , Chihara Y. , and Takahashi T. , Co-expression of receptor for advanced glycation end products and the ligand amphoterin associates closely with metastasis of colorectal cancer. Oncol Rep 10 (2003) 445-8.

Khorramdelazad H. , Bagheri V. , Hassanshahi G. , Karami H. , Moogooei M. , Zeinali M. , and Abedinzadeh M. , S100A12 and RAGE expression in human bladder transitional cell carcinoma: a role for the ligand/RAGE axis in tumor progression? Asian Pac J Cancer Prev 16 (2015) 2725-9.

Fuentes M.K. , Nigavekar S.S. , Arumugam T. , Logsdon C.D. , Schmidt A.M. , Park J.C. , and Huang E.H. , RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways. Dis Colon Rectum 50 (2007) 1230-40.

Sasahira T. , Kirita T. , Bhawal U.K. , Yamamoto K. , Ohmori H. , Fujii K. , and Kuniyasu H. , Receptor for advanced glycation end products (RAGE) is important in the prediction of recurrence in human oral squamous cell carcinoma. Histopathology 51 (2007) 166-72.

Bartling B. , Hofmann H.S. , Weigle B. , Silber R.E. , and Simm A. , Down-regulation of the receptor for advanced glycation end-products (RAGE) supports non-small cell lung carcinoma. Carcinogenesis 26 (2005) 293-301.

Michaelson J.S. , Silverstein M. , Sgroi D. , Cheongsiatmoy J.A. , Taghian A. , Powell S. , Hughes K. , Comegno A. , Tanabe K.K. , and Smith B. , The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 98 (2003) 2133-43.

Thompson R.H. , Kurta J.M. , Kaag M. , Tickoo S.K. , Kundu S. , Katz D. , Nogueira L. , Reuter V.E. , and Russo P. , Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol 181 (2009) 2033-6.

Sippel R.S. , Elaraj D.M. , Khanafshar E. , Zarnegar R. , Kebebew E. , Duh Q.Y. , and Clark O.H. , Tumor size predicts malignant potential in Hurthle cell neoplasms of the thyroid. World J Surg 32 (2008) 702-7.

Kiryushko D. , Novitskaya V. , Soroka V. , Klingelhofer J. , Lukanidin E. , Berezin V. , and Bock E. , Molecular mechanisms of Ca(2+) signaling in neurons induced by the S100A4 protein. Mol Cell Biol 26 (2006) 3625-38.

Merritt M.A. , and Cramer D.W. , Molecular pathogenesis of endometrial and ovarian cancer. Cancer Biomark 9 (2010) 287-305.

Wu J.T. , and Kral J.G. , The NF-kappaB/IkappaB signaling system: a molecular target in breast cancer therapy. J Surg Res 123 (2005) 158-69.

Arumugam T. , Ramachandran V. , and Logsdon C.D. , Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models. J Natl Cancer Inst 98 (2006) 1806-18.

Radia A.M. , Yaser A.M. , Ma X. , Zhang J. , Yang C. , Dong Q. , Rong P. , Ye B. , Liu S. , and Wang W. , Specific siRNA targeting receptor for advanced glycation end products (RAGE) decreases proliferation in human breast cancer cell lines. Int J Mol Sci 14 (2013) 7959-78.